Mitochondrial disease

Gene: SLC25A20

Green List (high evidence)

Carnitine-acylcarnitine translocase deficiency is a rare autosomal recessive metabolic disorder of long-chain fatty acid oxidation. Metabolic consequences include hypoketotic hypoglycemia under fasting conditions, hyperammonemia, elevated creatine kinase and transaminases, dicarboxylic aciduria, very low free carnitine and abnormal acylcarnitine profile with marked elevation of the long-chain acylcarnitines. Clinical features include neurologic abnormalities, cardiomyopathy and arrhythmias, skeletal muscle damage, and liver dysfunction. Most patients become symptomatic in the neonatal period with a rapidly progressive deterioration and a high mortality rate. However, presentations at a later age with a milder phenotype have been reported. Well established gene-disease association.

Created: 30 Dec 2020, 9:49 p.m. | Last Modified: 30 Dec 2020, 9:49 p.m.

Panel Version: 0.5879

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Carnitine-acylcarnitine translocase deficiency, MIM# 212138

Publications

• 15363639
• 15365988
• 24088670

Green List (high evidence)

>3 cases. Condition is a recessive disorder of mitochondrial fatty acid oxidation.
Sources: Literature, NHS GMS

Created: 20 Mar 2020, 8:19 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Carnitine-acylcarnitine translocase deficiency MIM#212138

Publications

• 9399886
• 31108048
• 25778941